Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma

[1]  K. Soo,et al.  Elderly Patients with Advanced Head and Neck Carcinoma: Does Aggressive Treatment Result in Better Outcomes? , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[2]  S. Bentzen,et al.  Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database. , 2018, Oral oncology.

[3]  S. Krishnan,et al.  Frailty in geriatric head and neck cancer: A contemporary review , 2018, The Laryngoscope.

[4]  R. Weber,et al.  NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[5]  G. Ruoppolo,et al.  Late radiation-associated dysphagia in head and neck cancer patients: evidence, research and management. , 2018, Oral oncology.

[6]  V. Tombolini,et al.  Osteoradionecrosis and intensity modulated radiation therapy: An overview. , 2016, Critical reviews in oncology/hematology.

[7]  R. Steenbakkers,et al.  CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  V. Tombolini,et al.  Treatment improvement and better patient care: which is the most important one in oral cavity cancer? , 2014, Radiation oncology.

[9]  H. Cohen,et al.  Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  E. Yorke,et al.  Use of normal tissue complication probability models in the clinic. , 2010, International journal of radiation oncology, biology, physics.

[11]  P. Sanghera,et al.  Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  J. Pignon,et al.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  M. Poulsen,et al.  Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Byung-Joo Lee,et al.  Induction chemotherapy of docetaxel and Cisplatin for the elderly patients with squamous cell carcinoma of the head and neck. , 2007, Cancer research and treatment : official journal of Korean Cancer Association.

[15]  Christopher U. Jones,et al.  Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.

[16]  Edward L Spitznagel,et al.  Prognostic importance of comorbidity in a hospital-based cancer registry. , 2004, JAMA.

[17]  Peijun Chen,et al.  The Mini‐Cog as a Screen for Dementia: Validation in a Population‐Based Sample , 2003, Journal of the American Geriatrics Society.

[18]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[19]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .